Philip Dayle continues to represent his clients in the ongoing infected blood inquiry which has been heard again this week in relation to the compensation delays to the victims.
The inquiry which began in 2018 was established to determine the circumstances in which patients treated by the NHS before 1996 received infected blood and blood products. More than 30,000 people in the UK were given treatments infected with HIV, hepatitis C and/or hepatitis B. The scandal has seen over 3,000 patients die due to the contaminated blood scandal.
The Inquiry’s report released in 2024 highlighted the need for improvements in medicine, government, and the civil service to prevent similar tragedies from occurring.
Interim payments of £100,000 each were made to about 4,000 surviving victims and bereaved partners in late 2022, following advice from the inquiry. However, Sir Brian Langstaff, chairman of the Infected blood inquiry is holding two days of special hearings to examine the “timeliness and adequacy of the Government’s response to compensation” as many could die before the compensation payment reaches them.
Philip Dayle is instructed by Saunders Law and have represented a small cohort of heamophiliac men who contracted by HIV and hepatitis C in the scandal , since the commencement of inquiry hearings in 2018.
